GlassScriptPhysician profile
Kristina V Fair
NPI 1477984953
$4,652.84
in general payments reported to CMS, 2019-2025
32 companies · $1,141 in 2025
The $1,141 reported for 2025 was more than what 87% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $221 · 2022: $698 · 2023: $1,305 · 2024: $1,288 · 2025: $1,141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,357 · Education: $377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,356.91 |
| Education | $376.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $875.23 | 2021-2025 | Erleada, Akeega, Balversa |
| Pfizer INC. | $522.97 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $484.56 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $366.04 | 2023-2025 | Gemtesa |
| Abbvie INC. | $328.80 | 2023-2025 | |
| Astellas Pharma US INC | $266.41 | 2021-2023 | Myrbetriq, Veozah |
| Astrazeneca Pharmaceuticals LP | $213.88 | 2023-2025 | Lynparza |
| Merck Sharp & Dohme LLC | $194.66 | 2021-2025 | Keytruda, Lynparza |
| 180 Medical, INC. | $166.19 | 2022-2025 | |
| Endo Pharmaceuticals INC. | $121.72 | 2022-2024 | Xiaflex, Aveed |
| Endo USA, INC. | $103.17 | 2024-2025 | Xiaflex, Aveed |
| Urovant Sciences INC | $99.89 | 2022 | |
| Sun Pharmaceutical Industries INC. | $94.58 | 2024 | |
| Tolmar, INC. | $90.90 | 2023-2025 | Jatenzo, Eligard |
| Dendreon Pharmaceuticals LLC | $87.46 | 2025 | Provenge |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $84.99 | 2025 | |
| Progenics Pharmaceuticals, INC. | $78.91 | 2023-2025 | Pylarify |
| Novartis Pharmaceuticals Corporation | $73.68 | 2024-2025 | |
| Boston Scientific Corporation | $54.40 | 2022-2024 | Ams 700 |
| Hollister Incorporated | $54.02 | 2022 | |
| Immunitybio, INC. | $51.92 | 2024-2025 | |
| Davol INC. | $50.77 | 2021 | |
| Urogen Pharma, INC. | $31.74 | 2024 | |
| Telix Pharmaceuticals | $30.10 | 2024 | Illuccix |
| Ferring Pharmaceuticals INC. | $21.91 | 2025 | Adstiladrin |
| Antares Pharma, INC. | $18.51 | 2025 | Xyosted |
| Axonics, INC. | $17.43 | 2022 | |
| Blue Earth Diagnostics | $14.98 | 2024 | |
| Tolmar Pharmaceuticals, INC. | $14.92 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.66 | 2022 | |
| Genzyme Corporation | $12.38 | 2022 | |
| Myriad Genetic Laboratories, INC. | $11.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristina Fair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.